[HTML][HTML] Patient-derived organoids as a predictive biomarker for treatment response in cancer patients
GE Wensink, SG Elias, J Mullenders… - NPJ precision …, 2021 - nature.com
Effective predictive biomarkers are needed to enable personalized medicine and increase
treatment efficacy and survival for cancer patients, thereby reducing toxic side effects and …
treatment efficacy and survival for cancer patients, thereby reducing toxic side effects and …
Patient-derived organoids as a predictive biomarker for treatment response in cancer patients.
GE Wensink, SG Elias, J Mullenders… - NPJ Precision …, 2021 - search.ebscohost.com
Effective predictive biomarkers are needed to enable personalized medicine and increase
treatment efficacy and survival for cancer patients, thereby reducing toxic side effects and …
treatment efficacy and survival for cancer patients, thereby reducing toxic side effects and …
Patient-derived organoids as a predictive biomarker for treatment response in cancer patients
WG Emerens, SG Elias, M Jasper… - NPJ Precision …, 2021 - search.proquest.com
Effective predictive biomarkers are needed to enable personalized medicine and increase
treatment efficacy and survival for cancer patients, thereby reducing toxic side effects and …
treatment efficacy and survival for cancer patients, thereby reducing toxic side effects and …
[PDF][PDF] Patient-derived organoids as a predictive biomarker for treatment response in cancer patients
GE Wensink, SG Elias, J Mullenders, M Koopman… - researchinformation.umcutrecht.nl
Despite advances in the treatment of cancer patients, the burden of cancer deaths remains
high, with 9, 5 million cancer deaths reported worldwide in 2018 1. A key limitation in cancer …
high, with 9, 5 million cancer deaths reported worldwide in 2018 1. A key limitation in cancer …
[HTML][HTML] Patient-derived organoids as a predictive biomarker for treatment response in cancer patients
GE Wensink, SG Elias, J Mullenders… - NPJ Precision …, 2021 - ncbi.nlm.nih.gov
Effective predictive biomarkers are needed to enable personalized medicine and increase
treatment efficacy and survival for cancer patients, thereby reducing toxic side effects and …
treatment efficacy and survival for cancer patients, thereby reducing toxic side effects and …
Patient-derived organoids as a predictive biomarker for treatment response in cancer patients
GE Wensink, SG Elias, J Mullenders… - NPJ precision …, 2021 - pubmed.ncbi.nlm.nih.gov
Effective predictive biomarkers are needed to enable personalized medicine and increase
treatment efficacy and survival for cancer patients, thereby reducing toxic side effects and …
treatment efficacy and survival for cancer patients, thereby reducing toxic side effects and …
Patient-derived organoids as a predictive biomarker for treatment response in cancer patients.
GE Wensink, SG Elias, J Mullenders… - NPJ Precision …, 2021 - europepmc.org
Effective predictive biomarkers are needed to enable personalized medicine and increase
treatment efficacy and survival for cancer patients, thereby reducing toxic side effects and …
treatment efficacy and survival for cancer patients, thereby reducing toxic side effects and …
[PDF][PDF] Patient-derived organoids as a predictive biomarker for treatment response in cancer patients
GE Wensink, SG Elias, J Mullenders, M Koopman… - academia.edu
Despite advances in the treatment of cancer patients, the burden of cancer deaths remains
high, with 9, 5 million cancer deaths reported worldwide in 2018 1. A key limitation in cancer …
high, with 9, 5 million cancer deaths reported worldwide in 2018 1. A key limitation in cancer …